US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 2.6200
  • -0.0300-1.13%
Close Jan 8 16:00 ET
  • 2.6200
  • 0.00000.00%
Post 16:00 ET
277.48MMarket Cap-8.45P/E (TTM)

ProQR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
131.45%21.55M
70.16%-5.32M
51.13%-7.51M
30.30%-10.35M
318.52%44.73M
-163.37%-68.51M
-571.15%-17.83M
Net income from continuing operations
-49.59%-8.11M
66.25%-2.69M
13.52%-7.66M
56.80%-27.74M
58.77%-5.48M
76.74%-5.42M
40.84%-7.98M
37.27%-8.86M
-5.60%-64.2M
23.38%-13.3M
Operating gains losses
91.34%-139K
11.76%-195K
110.15%68K
59.93%-1.08M
209.52%1.92M
-140.01%-1.61M
-256.45%-221K
82.16%-670K
-270.88%-2.71M
-396.28%-1.75M
Depreciation and amortization
7.17%688K
19.70%711K
25.87%691K
-0.32%2.51M
-2.67%728K
4.90%642K
0.51%594K
-3.68%549K
8.24%2.52M
35.51%748K
Deferred tax
--0
---200K
--3K
-181.25%-78K
--5K
-220.29%-83K
--0
--0
-17.95%96K
--0
Other non cash items
-29.20%-469K
10.16%-513K
-458.82%-488K
-463.48%-6.01M
-320.62%-5.72M
39.40%-363K
75.25%-571K
-83.45%136K
-12.44%1.65M
530.90%2.59M
Change In working capital
155.63%1.12M
-27.39%-4.61M
-117.64%-9.22M
1,080.89%48.96M
141.27%2.3M
-155.67%-2.01M
-495.41%-3.62M
1,423.80%52.29M
-119.95%-4.99M
-128.74%-5.56M
Cash from discontinued investing activities
Operating cash flow
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
131.45%21.55M
70.16%-5.32M
51.13%-7.51M
30.30%-10.35M
318.52%44.73M
-163.37%-68.51M
-571.15%-17.83M
Investing cash flow
Cash flow from continuing investing activities
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
709.40%4.28M
26,215.79%5M
-37.80%-339K
-27.27%-294K
63.52%-89K
-65.18%-702K
111.45%19K
Net PPE purchase and sale
15.63%-286K
9.18%-267K
-722.47%-732K
-86.75%-1.31M
-3,200.00%-589K
-37.80%-339K
-27.27%-294K
63.52%-89K
-65.18%-702K
111.45%19K
Net intangibles purchase and sale
----
----
----
--7.94M
----
----
----
----
--0
----
Net investment purchase and sale
--17M
--0
---17M
----
----
--0
--0
--0
----
----
Net other investing changes
----
----
----
---2.35M
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
709.40%4.28M
26,215.79%5M
-37.80%-339K
-27.27%-294K
63.52%-89K
-65.18%-702K
111.45%19K
Financing cash flow
Cash flow from continuing financing activities
-61.21%-453K
56.14%-282K
-61.78%-419K
92.64%-2.28M
-107.93%-1.09M
99.36%-281K
-80.11%-643K
52.30%-259K
-122.58%-30.89M
-48.92%13.76M
Net issuance payments of debt
-5.09%-454K
54.56%-294K
-124.32%-581K
94.16%-2.63M
-259.61%-1.29M
99.01%-432K
-81.23%-647K
55.03%-259K
-267.85%-45.05M
-101.35%-359K
Net common stock issuance
----
----
----
--0
----
----
----
----
-86.98%14.12M
----
Proceeds from stock option exercised by employees
-99.34%1K
200.00%12K
--162K
941.18%354K
19,800.00%199K
--151K
--4K
--0
-97.76%34K
-99.72%1K
Cash from discontinued financing activities
Financing cash flow
-61.21%-453K
56.14%-282K
-61.78%-419K
92.64%-2.28M
-107.93%-1.09M
99.36%-281K
-80.11%-643K
52.30%-259K
-122.58%-30.89M
-48.92%13.76M
Net cash flow
Beginning cash position
-38.57%78.97M
-38.33%85.71M
25.48%118.93M
-49.46%94.78M
20.03%120.55M
-17.80%128.56M
-17.08%138.99M
-49.46%94.78M
147.27%187.52M
-35.68%100.43M
Current changes in cash
230.46%10.6M
39.69%-6.81M
-175.00%-33.28M
123.53%23.55M
65.09%-1.41M
86.31%-8.13M
26.88%-11.28M
308.79%44.38M
-190.67%-100.1M
-113.25%-4.05M
Effect of exchange rate changes
-246.61%-173K
-92.79%62K
142.77%71K
-91.85%599K
86.74%-213K
-96.52%118K
-79.63%860K
-112.37%-166K
469.40%7.35M
-295.85%-1.61M
End cash Position
-25.84%89.4M
-38.57%78.97M
-38.33%85.71M
25.48%118.93M
25.48%118.93M
20.03%120.55M
-17.80%128.56M
-17.08%138.99M
-49.46%94.78M
-49.46%94.78M
Free cash flow
24.26%-5.94M
38.70%-6.52M
-135.58%-15.86M
129.15%20.18M
66.76%-5.92M
49.73%-7.85M
29.41%-10.64M
315.29%44.59M
-161.23%-69.22M
-600.56%-17.82M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.65%-5.66M39.54%-6.26M-133.83%-15.13M131.45%21.55M70.16%-5.32M51.13%-7.51M30.30%-10.35M318.52%44.73M-163.37%-68.51M-571.15%-17.83M
Net income from continuing operations -49.59%-8.11M66.25%-2.69M13.52%-7.66M56.80%-27.74M58.77%-5.48M76.74%-5.42M40.84%-7.98M37.27%-8.86M-5.60%-64.2M23.38%-13.3M
Operating gains losses 91.34%-139K11.76%-195K110.15%68K59.93%-1.08M209.52%1.92M-140.01%-1.61M-256.45%-221K82.16%-670K-270.88%-2.71M-396.28%-1.75M
Depreciation and amortization 7.17%688K19.70%711K25.87%691K-0.32%2.51M-2.67%728K4.90%642K0.51%594K-3.68%549K8.24%2.52M35.51%748K
Deferred tax --0---200K--3K-181.25%-78K--5K-220.29%-83K--0--0-17.95%96K--0
Other non cash items -29.20%-469K10.16%-513K-458.82%-488K-463.48%-6.01M-320.62%-5.72M39.40%-363K75.25%-571K-83.45%136K-12.44%1.65M530.90%2.59M
Change In working capital 155.63%1.12M-27.39%-4.61M-117.64%-9.22M1,080.89%48.96M141.27%2.3M-155.67%-2.01M-495.41%-3.62M1,423.80%52.29M-119.95%-4.99M-128.74%-5.56M
Cash from discontinued investing activities
Operating cash flow 24.65%-5.66M39.54%-6.26M-133.83%-15.13M131.45%21.55M70.16%-5.32M51.13%-7.51M30.30%-10.35M318.52%44.73M-163.37%-68.51M-571.15%-17.83M
Investing cash flow
Cash flow from continuing investing activities 5,030.38%16.71M9.18%-267K-19,823.60%-17.73M709.40%4.28M26,215.79%5M-37.80%-339K-27.27%-294K63.52%-89K-65.18%-702K111.45%19K
Net PPE purchase and sale 15.63%-286K9.18%-267K-722.47%-732K-86.75%-1.31M-3,200.00%-589K-37.80%-339K-27.27%-294K63.52%-89K-65.18%-702K111.45%19K
Net intangibles purchase and sale --------------7.94M------------------0----
Net investment purchase and sale --17M--0---17M----------0--0--0--------
Net other investing changes ---------------2.35M------------------------
Cash from discontinued investing activities
Investing cash flow 5,030.38%16.71M9.18%-267K-19,823.60%-17.73M709.40%4.28M26,215.79%5M-37.80%-339K-27.27%-294K63.52%-89K-65.18%-702K111.45%19K
Financing cash flow
Cash flow from continuing financing activities -61.21%-453K56.14%-282K-61.78%-419K92.64%-2.28M-107.93%-1.09M99.36%-281K-80.11%-643K52.30%-259K-122.58%-30.89M-48.92%13.76M
Net issuance payments of debt -5.09%-454K54.56%-294K-124.32%-581K94.16%-2.63M-259.61%-1.29M99.01%-432K-81.23%-647K55.03%-259K-267.85%-45.05M-101.35%-359K
Net common stock issuance --------------0-----------------86.98%14.12M----
Proceeds from stock option exercised by employees -99.34%1K200.00%12K--162K941.18%354K19,800.00%199K--151K--4K--0-97.76%34K-99.72%1K
Cash from discontinued financing activities
Financing cash flow -61.21%-453K56.14%-282K-61.78%-419K92.64%-2.28M-107.93%-1.09M99.36%-281K-80.11%-643K52.30%-259K-122.58%-30.89M-48.92%13.76M
Net cash flow
Beginning cash position -38.57%78.97M-38.33%85.71M25.48%118.93M-49.46%94.78M20.03%120.55M-17.80%128.56M-17.08%138.99M-49.46%94.78M147.27%187.52M-35.68%100.43M
Current changes in cash 230.46%10.6M39.69%-6.81M-175.00%-33.28M123.53%23.55M65.09%-1.41M86.31%-8.13M26.88%-11.28M308.79%44.38M-190.67%-100.1M-113.25%-4.05M
Effect of exchange rate changes -246.61%-173K-92.79%62K142.77%71K-91.85%599K86.74%-213K-96.52%118K-79.63%860K-112.37%-166K469.40%7.35M-295.85%-1.61M
End cash Position -25.84%89.4M-38.57%78.97M-38.33%85.71M25.48%118.93M25.48%118.93M20.03%120.55M-17.80%128.56M-17.08%138.99M-49.46%94.78M-49.46%94.78M
Free cash flow 24.26%-5.94M38.70%-6.52M-135.58%-15.86M129.15%20.18M66.76%-5.92M49.73%-7.85M29.41%-10.64M315.29%44.59M-161.23%-69.22M-600.56%-17.82M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data